Amphivena Therapeutics
PrivateLast Round
Series C
Sep 24, 2019
Total Funding Raised
$95.5M
Company Overview
Amphivena Therapeutics is a clinical-stage immuno-oncology company that develops bivalent T-cell engagers for the treatment of hematologic and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amphivena Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Amphivena Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 24, 2019 | ||||
| Series B | Jun 26, 2017 | ||||
| Series A | Jul 1, 2013 |
Amphivena Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MPM Capital | Series C, Series A |
| Korys | Series C |
| Kaitai Capital | Series C |
| Aeris Capital Management | Series A, Series B |
| +ND Capital | Series C |
| MPM BioImpact | Series C, Series A, Series B |
| OrbiMed | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 24, 2019
$62M round led by +ND Capital.
Amphivena Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Amphivena Therapeutics's valuation, stock price, and market status.